Liu XH - Search Results

1

[Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].

Zhang GM, Sui LH, Jia T, Zhao YZ, Fu SB, Liu XH, Yu Y. Zhang GM, et al. Among authors: liu xh. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):170-3. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756929 Chinese.

2

Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY. Zhang GM, et al. Among authors: liu xh. Chin Med J (Engl). 2008 Nov 20;121(22):2324-30. Chin Med J (Engl). 2008. PMID: 19080341

3

[Optimization of extracting method and inhibitory action of recombinant human endostatin in bladder cancer].

Ren MH, Ni SB, Chen QY, Xu WH, Wang CL, Fu YM, Jiao ZX, Ma L, Zhao ZS, Liu XH. Ren MH, et al. Among authors: liu xh. Zhonghua Yi Xue Za Zhi. 2009 Dec 15;89(46):3285-8. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20193369 Chinese.

4

The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma.

Li YJ, Sun LC, He Y, Liu XH, Liu M, Wang QM, Jin XM. Li YJ, et al. Among authors: liu xh, liu m. Acta Pharmacol Sin. 2009 Sep;30(9):1307-15. doi: 10.1038/aps.2009.111. Epub 2009 Aug 24. Acta Pharmacol Sin. 2009. PMID: 19701238 Free PMC article.

5

19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo.

He Y, Jiang Y, Li YJ, Liu XH, Zhang L, Liu LJ, Shi H, Li HN, Ma YC, Jin XM. He Y, et al. Among authors: liu xh, liu lj. J Gastroenterol Hepatol. 2010 May;25(5):935-41. doi: 10.1111/j.1440-1746.2009.06209.x. J Gastroenterol Hepatol. 2010. PMID: 20546447

6

Dynamic changes of territories 17 and 18 during EBV-infection of human lymphocytes.

Li C, Shi Z, Zhang L, Huang Y, Liu A, Jin Y, Yu Y, Bai J, Chen D, Gendron C, Liu X, Fu S. Li C, et al. Mol Biol Rep. 2010 Jun;37(5):2347-54. doi: 10.1007/s11033-009-9740-y. Epub 2009 Aug 15. Mol Biol Rep. 2010. PMID: 19685159

7

Mitochondria-mediated tumstatin peptide-induced HepG2 cell apoptosis.

Liu Y, Li J, Xu H, Zhang Y, Liu Y, Liu X. Liu Y, et al. Int J Mol Med. 2009 Nov;24(5):653-9. doi: 10.3892/ijmm_00000276. Int J Mol Med. 2009. PMID: 19787199

8

A comparative study of tumor-suppression effects of enterotoxin B and Chalone 19-peptide on experimental gastric carcinoma.

Huan Y, He Y, Liu M, Jin X, Li X, Liu X, Zhang Q. Huan Y, et al. Hepatogastroenterology. 2009 Jan-Feb;56(89):270-5. Hepatogastroenterology. 2009. PMID: 19453073

9

RGD-modified endostatin peptide 30 derived from endostatin suppresses invasion and migration of HepG2 cells through the αvβ3 pathway.

Li S, Wei J, Yuan L, Sun H, Liu Y, Zhang Y, Li J, Liu X. Li S, et al. Cancer Biother Radiopharm. 2011 Oct;26(5):529-38. doi: 10.1089/cbr.2011.0978. Epub 2011 Aug 11. Cancer Biother Radiopharm. 2011. PMID: 21834652

10

PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.

Yu S, Li L, Tian W, Nie D, Mu W, Qiu F, Liu Y, Liu X, Wang X, Du Z, Chu WF, Yang B. Yu S, et al. Br J Pharmacol. 2018 Aug;175(15):3111-3130. doi: 10.1111/bph.14352. Epub 2018 Jun 15. Br J Pharmacol. 2018. PMID: 29722931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,390 results

Search Page

Filters